Abstract The coronavirus disease 2019 (COVID-19) pandemic has brought challenges to
clinicians caring for patients with chronic liver disease. In the past 6 months, COVID-19 has …

Background: The disease severity, ranging from being asymptomatic to having acute illness,
and associated inflammatory responses has suggested that alterations in the gut microbiota …

Background The COVID-19 pandemic has impacted every individual's life. It has been
shown that mortality in people with underlying diseases including diabetes has been very …

Aims We aimed to compare the clinical outcomes and imaging findings between COVID-19
patients with well-controlled diabetes and those with poorly-controlled diabetes. Methods In …

This comprehensive review aimed to evaluate the relationship between SARS-CoV-2
infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and …

Abstract The coronavirus disease 2019 (COVID-19) is a novel global pandemic infectious
disease with a higher potential for outbreaks than the other epidemic disease such as …

Although various pharmacologic agents are under active study [1], there are currently no
effective and evidence-based antiviral drugs or drug combinations against severe acute …

Aims: This study aimed to investigate the clinical courses and outcomes of diabetes mellitus
patients with coronavirus disease 2019 (COVID-19) in Wuhan. Methods: This study enrolled …

Abstract Aim Individuals with SARS-CoV-2 infection and (pre-existing) diabetes, including
pregnant women, present with more severe morbidity, as compared to non-diabetic subjects …

With no known treatments or vaccine, COVID-19 presents a major threat, particularly to older
adults, who account for the majority of severe illness and deaths. The age-related …